Medical/Pharmaceuticals

South and East Asia identified as hotspots of global warming related impacts on male fertility

BEIJING, May 9, 2026 /PRNewswire/ -- A major new study has shown that South and East Asia dominate patterns of global warming related decline in male fertility with the strongest and most consistent evidence coming from India, Pakistan and the southern parts of China. The effects of increased ...

2026-05-09 15:01 2235

Psychosocial support is vital to help those living with infertility to overcome treatment barriers, including stigmas, myths and taboos about IVF

BEIJING, May 9, 2026 /PRNewswire/ -- Diverse cultural or religious values across the Asia Pacific region mean that many people living with infertility face challenging family or societal attitudes when considering assisted reproductive treatment to achieve their dreams of parenthood. In many c...

2026-05-09 09:00 3294

AAVnerGene Announces AAVone®2.1, a Next-Generation Single-Plasmid AAV Production Platform Achieving ~1e16 GC/L and >70% Full Capsids at Harvest

ROCKVILLE, Md., May 8, 2026 /PRNewswire/ -- USA -- AAVnerGene Inc. today announced the launch of AAVone®2.1, the next-generation evolution of its proprietary AAVone® single-plasmid AAV production system, designed to improve AAV vector productivity, full-capsid yield, manufacturing efficiency, and...

2026-05-08 20:26 3698

The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted for Review by NMPA

CHENGDU, China, May 8, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company") announced that the sNDA (the "Application") for the Company's TROP2 ADC sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) was accepted for review ...

2026-05-08 19:29 3191

What Sets Medtec China Apart from Other Medical Device Manufacturing Expos

SHANGHAI, May 8, 2026 /PRNewswire/ -- Building a successful medical device requires precise engineering, reliable materials, and a resilient supply chain. Finding the right partners to bring your vision to life is a major challenge. TheMedtec China trade show solves ...

2026-05-08 19:21 2930

For the Reasons that Matter: A Multi-Spotlight Campaign Puts Adult Respiratory Health in Focus

JAKARTA, Indonesia, May 7, 2026 /PRNewswire/ -- In conjunction with World Immunization Week, Pfizer Indonesia, together with healthcare professionals has launched "For the Reasons that Matter", a public awareness campaign focused on adult respiratory health. Rolling out simultaneously across Indo...

2026-05-07 23:05 2717

Fertility patients vulnerable to social media overload of misleading data where evidence and algorithms collide

BEIJING, May 7, 2026 /PRNewswire/ -- Patient information overload dominated by misleading social media and marketing is causing patients experiencing infertility to have unrealistic expectations about treatment success often resulting in psychological distress. "Never before have patients had ...

2026-05-07 14:53 2277

AID 2026 to Showcase Booming Opportunities in Silver Economy

SHANGHAI, May 7, 2026 /PRNewswire/ -- International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare, Shanghai 2026 (hereinafter referred to as AID 2026), widely recognized as China's leading event for the senior care and silver economy sectors, will be held on June 4–6 at Shangh...

2026-05-07 09:00 2262

Move towards global consensus guidelines on surrogacy with mounting concerns over human rights violations

BEIJING, May 7, 2026 /PRNewswire/ -- World leaders in assisted reproductive technology are finalising global consensus guidelines on minimal standards in surrogacy to address mounting concerns about severe human rights violations. The standards will attempt to tackle inconsistent or inadequate ...

2026-05-07 09:00 2561

ABEC Expands Process Sciences Group to Strengthen Bioprocess Optimization Capabilities

BETHLEHEM, Pa., May 6, 2026 /PRNewswire/ -- ABEC, a global leader in bioprocess engineering solutions, announced the expansion of itsProcess Sciences group, expanding its ability to help biopharmaceutical manufacturers accelerate development, reduce risk, and improve productivity across the biopr...

2026-05-06 22:09 2318

Ribo and Boehringer Ingelheim further progress their siRNA program for metabolic dysfunction-associated steatohepatitis (MASH)

SUZHOU, China and MÖLNDAL, Sweden, May 6, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB ("Ribo", HKEX: 6938) today announced the achievement of a further milestone. This marks the third key milestone achieved in the research collaboration with Boehringer ...

2026-05-06 19:32 2166

China Medical Exhibition 2026: Industries, Products, and Innovations to Watch

SHANGHAI, May 6, 2026 /PRNewswire/ -- The medical device industry moves fast. To stay competitive, you must source the best materials and adopt the latest manufacturing technology before your rivals do. Medtec China serves as the ultimate proving ground for these br...

2026-05-06 17:53 2096

The GBA Healthcare Group and Adventist Health Hong Kong Forge Strategic Partnership for Seamless Specialty Care

Pooling Guangdong–Hong Kong clinical strengths to deliver an end-to-end cross-border care ecosystem spanning direct billing, fast-track referrals and precision specialty matching HONG KONG, May 6, 2026 /PRNewswire/ -- The GBA Healthcare Group ("GBAH") and Adventist Health Hong Kong ("AHHK") toda...

2026-05-06 15:00 2764

MingMed Biotechnology Presents Positive Phase II Data of Oral QA102 for the Treatment of Intermediate Age-Related Macular Degeneration (AMD) at Association for Research in Vision and Ophthalmology (ARVO) 2026

GUANGZHOU, China, May 6, 2026 /PRNewswire/ -- MingMed Biotechnology Co., Ltd, a biomedical firm focused on the discovery and development of novel therapeutics across multiple therapeutic areas, announced positive results from its Phase II clinical trial of QA102 in patients with intermediate dry ...

2026-05-06 08:28 2698

Ascletis to Present Data on Multiple Programs at the 33rd European Congress on Obesity (ECO 2026)

HONG KONG, May 6, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today poster presentations highlighting multiple programs at the 33rd European Congress on Obesity (ECO 2026), taking place May 12-15, 2026 in Istanbul, Türkiye. The presentations include a poster on...

2026-05-06 08:10 2280

Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1

* PEDMARQSI® is now TGA registered in Australia for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to <18 years of age with localised, non-metastatic, solid tumours * TGA registration provides an approved treatment option in an area of significant unmet me...

2026-05-06 05:01 2451

AI Model Analyses Body Composition to Predict Health Risks

OAK BROOK, Ill., May 5, 2026 /PRNewswire/ -- Researchers used AI to analyze whole-body MRI scans from more than 66,000 participants to create the most detailed reference map to date of how fat and muscle are distributed in the human body across age, sex and height. The study was published today i...

2026-05-05 22:00 2136

Hidden Muscle Fat Poses Danger to Heart, Metabolism

OAK BROOK, Ill., May 5, 2026 /PRNewswire/ -- Using a deep learning model to analyze the composition of large muscles on MRI, German researchers found that the proportions of intermuscular fat and lean muscle mass were associated with high blood pressure and unhealthy lipid and blood sugar levels....

2026-05-05 22:00 2030

BostonGene Receives Frost & Sullivan's 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms

Recognition highlights BostonGene's leadership in improving drug development decisions, reducing risk and accelerating patient impact SAN ANTONIO, May 5, 2026 /PRNewswire/ -- Frost & Sullivan

2026-05-05 22:00 2904

3Shape appoints new Chief Financial Officer

COPENHAGEN, Denmark, May 5, 2026 /PRNewswire/ -- 3Shape today announced the appointment of Stefan Kratzer as Chief Financial Officer effective 5 May. He will join the Senior Leadership Team and report directly to CEO Jacob Paulsen. The appointment ensures strong leadership continuity, with an exp...

2026-05-05 19:26 2001
12345 ... 393